India's COVID-19 tally crosses 57 lakh, 86,508 test positive in 24 hrs; expect dip in Delhi cases, says Kejriwal
So far, a total of 46,74,987 people have recuperated from COVID-19 and the recovery rate stands at 81.55 percent, showed the health ministry's data updated at 8 am.
With 86,508 more testing positive for the coronavirus over the past 24 hours, the total cases in India on Thursday climbed to 57,32,518, while the toll reached 91,149 with 1,129 fatalities.
Recoveries exceeded new infections for the sixth consecutive day, with a total of 87,374 people recuperating from the disease in a span of 24 hours, as per the health ministry.
So far, India has clocked 46,74,987 recoveries and the recovery rate stands at 81.55 percent, showed the health ministry's data updated at 8 am.
Following the national trend, 13 states and UTs are also reporting a higher number of new recoveries than new cases, said the ministry.
It further said that nearly 74 percent of the new COVID-19 recoveries are from 10 states and Union Territories: Maharashtra, Karnataka, Andhra Pradesh, UP, Tamil Nadu, Odisha, Delhi, Kerala, West Bengal and Chhattisgarh. Maharashtra has maintained this lead with 19,476 recoveries (22.3 percent) for the sixth consecutive day.
With the increasing number of recoveries, India now has 9,66,382 active cases, which accounts for 16.86 percent of the total cases detected in the country, showed the ministry's data.
According to the Indian Council for Medical Research (ICMR),a cumulative total of 6,74,36,031 samples have been tested up to 23 September, of which 11,56,569 samples were tested on Wednesday.
'Cases in Delhi expected to dip'
Delhi chief minister Arvind Kejriwal said the second wave of coronavirus infections has hit its peak in the National Capital and experts had hinted that the cases were likely to decline in the next few days.
Delhi has been witnessing a surge in the number of coronavirus cases in the last few days and has so far recorded over 2.60 lakh cases and 5,123 deaths.
The city was reporting a daily average of 1,100 to 1,200 between 1 July and 17 August but after that, the new cases rose lightly to around 1,500, said Kejriwal, adding that testing was immediately scaled up from around 20,000 to 60,000 tests per day.
The chief minister said the state government was "keeping its fingers crossed" and hoping that the COVID-19 cases will "gradually" come down due to the steps taken by it.
Increase contact-tracing, Adityanath tells officials
In Uttar Pradesh, Chief Minister Yogi Adityanath asked senior officials to focus on districts that have reported 100 or more cases per day in the past one week in order to arrest the spread of the infection. Aditynath instructed that nodal officers and a special secretary-level officer be deputed in each such district.
The chief minister asked officials to ramp up contact-tracing, adding that special attention should be given on testing the high-risk groups.
He also directed them to keep ventilators/HFNC (high-flow nasal cannula, a non-invasive respiratory support system for oxygen supply) active in all districts, it added.
Telangana to resume inter-state buses
The Telangana government decided to resume bus services in Hyderabad from 25 September. Inter-state bus services from Telangana to Karnataka and Maharashtra will also resume from Friday, an official release said on Thursday.
Transport minister P Ajay Kumar said 25 percent of the nearly 2,800 buses in 29 depots of Telangana State Road Transport Corporation (TSRTC) in Greater Hyderabad would be operational.
The city bus services have been under suspension since March as part of the lockdown announced to contain coronavirus.
Tarun Gogoi moved to ICU
In Assam, former chief minister Tarun Gogoi was shifted to the ICU as his oxygen levels fell due to post-COVID complications. The 85-year-old leader had tested positive for the virus on 25 August and was admitted to the Gauhati Medical College and Hospital (GMCH) the next day.
He tested negative recently but remained in the hospital.
Gogoi, who has "a lot of comorbid conditions", was admitted to the ICU as he developed some problems in the lungs and his oxygen level
dropped drastically informed GMCH superintendent Abhijit Sarma.
The hospital official added that the leader's condition had stabilised. "However, he is stable now and we are constantly monitoring his condition. He is in oxygen support at this moment," he said.
Delhi deputy chief Minister Manish Sisodia, who was hospitalised for COVID-19 on Wednesday, tested positive for dengue, sources told news agency PTI. They said the deputy CM's platelet count has also dropped.
Sisodia had tested positive on 14 Septemeber and was initially under home isolation.
SPB's condition critical, Maharashtra minister tests positive
In Tamil Nadu, the hospital treating singer SP Balasubrahmanyam said he is extremely critical while in Maharashtra, urban development minister Eknath Shinde said he has tested positive.
Shinde had attended the state cabinet meeting earlier this week and is the 13th minister in the state to have tested positive.
"I got myself tested for COVID-19 yesterday and the reports have returned positive. Health is fine thanks to the blessings of you all. Requesting all who came in my contact over the past some days to take proper care and get themselves tested," the minister tweeted in Marathi.
Meanwhile, Chennai's MGM Healthcare said the 74-year-old singer, popularly known as SPB "remains on ECMO (extracorporeal membrane oxygenation) and other life support measures."
"His condition in the last 24 hours has deteriorated further warranting maximal life support and he is extremely critical," assistant director (Medical Services), MGM Healthcare, Dr Anuradha Baskaran said in a statement, adding that a team of doctors was monitoring his condition.
The health condition of the singer, who was admitted to the hospital with mild symptoms on 5 August, deteriorated for the first time on the night of 13 August. He was put on life support and moved to the Intensive Care Unit.
UK may conduct 'challenge trials'
On the vaccine front, scientists in the UK said they are heading towards an approach being referred to as challenge trials, which involves healthy volunteers being deliberately infected with the novel coronavirus to test the efficacy of vaccines.
The Financial Times reported that the first of its kind trial is expected to be formally announced next week and the government-funded study is expected to begin in January.
Participants will be injected with an unnamed experimental vaccine and around a month later exposed to Sars-Cov-2, the virus that causes COVID-19, the report stated.
Around 2,000 potential volunteers have signed up for challenge studies in the UK through the US-based group 1Day Sooner, and are expected to be paid a few thousand pounds for participating in the upcoming trials, according to the newspaper.
The project's academic leader is Imperial College London, and it will be run by hVivo, a spinout from Queen Mary University of London that was bought earlier this year by Open Orphan, an Ireland-based pharmaceutical research organisation.
Oxford University is also believed to be considering a similar "challenge trial" to test whether people have protective immunity from COVID-19 if they have been previously infected.
Any trial that involves exposing people to the virus would need the approval of the UK Medicines and Healthcare products Regulatory Agency (MHRA), as well as an independent research committee.
The virus has infected 3,19,44,038 persons across the world and claimed 9,77,881 lives, according to the John Kopkins University's coronavirus tracker. US has reported the highest number of deaths, followed by Brazil and India. In terms of cases, US again tops the list followed by India and Brazil.
With inputs from PTI
Centre says no major mutation in coronavirus in India; active cases fall below 8 lakh after over a month
The term 'mutation' typically refers to the tendency of a virus to undergo changes when it multiplies, causing the virus to develop some new strains. This could hinder the development of an effective vaccine
India's medical students can be trained to vaccinate half the population against COVID-19 by Dec 2021
India needs to leverage its medical student population to ensure the human resources needed to vaccinate half the population in six to eight months.
Second COVID-19 wave can't be ruled out, states NITI Aayog's VK Paul; Centre says community transmission limited
Vardhan added, "In different pockets across various states, including West Bengal, community transmission of COVID-19 is expected to occur, especially in densely-populated areas."